Data as of Aug 21
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for LifeVantage Corp have a median target of 2.55, with a high estimate of 3.00 and a low estimate of 2.10. The median estimate represents a +96.15% increase from the last price of 1.30.
The current consensus among 2 polled investment analysts is to Buy stock in LifeVantage Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.